Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer

A subset of breast cancer patients benefits from preoperative bevacizumab and chemotherapy, but validated predictive biomarkers are lacking. Here, we aimed to evaluate tissue-based angiogenesis markers for potential predictive value regarding response to neoadjuvant bevacizumab treatment in breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Krüger, Kristi, Silwal-Pandit, Laxmi, Wik, Elisabeth, Straume, Oddbjørn, Stefansson, Ingunn M., Borgen, Elin, Garred, Øystein, Naume, Bjørn, Engebraaten, Olav, Akslen, Lars A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873274/
https://www.ncbi.nlm.nih.gov/pubmed/33564016
http://dx.doi.org/10.1038/s41598-021-81914-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873274/
https://www.ncbi.nlm.nih.gov/pubmed/33564016
http://dx.doi.org/10.1038/s41598-021-81914-0

Ejemplares similares